Cardinal Health plans to divest its Pharmaceutical Technologies and Services (PTS) segment, a business that manufactures or packages 100 billion doses of medication annually for pharma and biopharma firms. The segment employs approximately 10,000 people at more than 30 facilities worldwide and generates $1.8 billion in revenue. “In the coming years, Cardinal Health will focus more on our products and services that help providers improve the safety and productivity of health care,&#822...